Perfluorohexyloctane ophthalmic solution - Novaliq
Alternative Names: MIEBO; NOV 03; Novatears; NOVO-3; SHR 8058 eye dropsLatest Information Update: 30 Dec 2024
At a glance
- Originator Novaliq
- Developer Bausch Health Companies; Jiangsu Hengrui Medicine Co.; Novaliq
- Class Eye disorder therapies; Fluorocarbons; Small molecules
- Mechanism of Action Lipid modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Dry eyes